Status:

COMPLETED

APIOC for Presbyopia and APIOC for Presbyopia With Astigmatism

Lead Sponsor:

Lentechs, LLC

Conditions:

Presbyopia

Myopia

Eligibility:

All Genders

40-70 years

Phase:

NA

Brief Summary

Vision and comfort, both objective and subjective, will be assessed for single vision contact lens wearers for either the APIOC™ for Presbyopia or the APIOC™ for Presbyopia Astigmatism contact lenses.

Eligibility Criteria

Inclusion

  • The subject must provide written informed consent.
  • The subject must appear willing and able to adhere to the instructions set forth in this protocol.
  • At least 40 years of age and no more than 70 years of age.
  • ≤ 4.00 D of corneal astigmatism.
  • ≤ 2.50 D of refractive astigmatism.
  • Refractive error range +4.00 DS to -6.00 DS
  • Require a reading addition (bifocal) of at least 0.75 D
  • Flat and steep keratometry readings within 40 to 48 D.
  • Clear, healthy corneas with no irregular astigmatism.
  • Normal, healthy conjunctiva in both eyes.
  • Free of active ocular disease. Refractive error and presbyopia are permitted.
  • Be a current or former (within the last 3 years) contact lens wearer.
  • Best-corrected near and distance visual acuity better than or equal to 20/25.

Exclusion

  • Irregular corneal astigmatism.
  • Corneal scarring unless off line-of-site and well healed.
  • Pinguecula, pterygium, or other conjunctival thickness abnormalities that would interfere with soft contact lens wear.
  • Recent use of any ocular pharmaceutical treatments, including daily artificial tears, in the two weeks prior to the examination. Occasional artificial tear use is permitted.
  • Systemic disease that would interfere with contact lens wear.
  • Currently pregnant or lactating (by self-report).
  • History of strabismus or eye movement disorder, including exophoria at near that is 4 D or greater than at far, and a receded near point of convergence break that is 6 cm or greater.
  • Active allergies that may inhibit contact lens wear.
  • Upper eyelid margin at or above the superior limbus.
  • History of ocular or lid surgery.
  • Immediate family members or significant others of doctors or staff at the clinical site.

Key Trial Info

Start Date :

May 6 2021

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

October 31 2021

Estimated Enrollment :

50 Patients enrolled

Trial Details

Trial ID

NCT04883099

Start Date

May 6 2021

End Date

October 31 2021

Last Update

January 19 2022

Active Locations (6)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 2 (6 locations)

1

Complete Family Vision Care

San Diego, California, United States, 92123

2

Eola Eyes

Orlando, Florida, United States, 32803

3

Gaddie Eye Centers

Lexington, Kentucky, United States, 40517

4

Miamisburg Vision Care

Miamisburg, Ohio, United States, 45342